| NCT07303582 | Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities | Oxford University Hospitals NHS Trust | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
| Recruiting | 50 | PHASE4 | Drug | Pain | - Ashworth and Modified Ashworth Scale (MAS)
- Barthel Index (BI)
- European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L)
- Goal Attainment Scaling (GAS) score
- Neuropathoc Pain Symptom Inventory (NPSI)
- Surface Electromyography (sEMG)
| 24 weeks | 02 December 2025 | 26 December 2025 | 1 | |
| NCT07251491 | Psilocybin to Treat Depression in Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age ≥ 22 yrs
- Level C1-S5
AIS - ≥ 12 months
- have a confirmed diagnosis of depression
| Recruiting soon | 30 | PHASE1, PHASE2 | Drug | Mental health and psychosocial factors | - Adverse Events (AEs)
- Beck Depression Inventory (BDI)
| 13 months | 01 January 2026 | 26 November 2025 | 1 | |
| NCT06793683 | Early BOTOX After Spinal Cord Injury | University of Washington | | - Age 18 - 65 yrs
- Level C1-T6
AIS A, B- ≤ 20 weeks
| By invitation | 10 | EARLY_PHASE1 | Drug | Bladder health/function | - Adverse Events (AEs)
- Feasibility
| 1 year | 27 July 2024 | 27 January 2025 | 1 | |
| NCT07343583 | Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury | Ankara City Hospital Bilkent | | - Age 18 - 65 yrs
- Level C1-T11
AIS - ≤ 6 months
- NOT have a cardiac pacemaker
| Recruiting | 45 | NA | Technology | Bladder health/function | - Neurogenic Bladder Symptom Score
- Neurogenic Bowel Dysfunction Score (NBD or NBDS)
- Spinal Cord Independence Measure (SCIM)
- Urodynamic examination
| 2 months | 05 August 2025 | 15 January 2026 | 1 | |
| NCT07359677 | High-frequency Alternating Current Stimulation for Neurophatic Pain in Spinal Cord Injury | University of Castilla-La Mancha | | - Age ≥ 18 yrs
- Level T1-S5
AIS A, B, C, D- ≥ 3 months
- NOT have a cardiac pacemaker or any other implanted electrical device
| Recruiting | 30 | NA | Technology | Pain | - Adverse Events (AEs)
- Ashworth and Modified Ashworth Scale (MAS)
- Neuropathoc Pain Symptom Inventory (NPSI)
- Pain Visual Analog Scale (VAS)
- Penn Spasm Frequency Scale (PSFS)
| 15 days | 30 January 2026 | 22 January 2026 | 1 | |
| NCT07293780 | Effect of TMS on Neuropathic Pain for Patients With Sci | Ankara Etlik City Hospital | | - Age 18 - 65 yrs
- Level C1-S5
AIS - ≥ 12 months
- NOT have metallic implants in the scalp, cochlear implants, pacemaler or spinal cord stimulator
- Have central, neuropathic pain.
| Recruiting | 39 | NA | Technology | Pain | - Beck Depression Inventory (BDI)
- Pain Visual Analog Scale (VAS)
| 12 weeks | 15 December 2025 | 19 December 2025 | 2 | |
